tiprankstipranks
Codex DNA (DNAY)
NASDAQ:DNAY
US Market

Codex DNA (DNAY) Cash flow

0 Followers

Codex DNA Cash Flow

DNAY's free cash flow for Q was $-15.49M. For the fiscal year, DNAY's free cash flow was decreased by $-22.97M and operating cash flow was $-15.10M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19
Operating Cash Flow
$ -45.52M$ -36.70M$ -15.38M$ -6.39M
Investing Cash Flow
$ -43.76M$ -15.04M$ -204.00K$ -79.00K
Financing Cash Flow
$ 4.39M$ 121.08M$ -96.00K$ 35.11M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ 161.36M$ 82.81M$ 13.46M$ 29.14M
Income Tax Paid Supplemental Data
--$ 0.00$ 0.00
Interest Paid Supplemental Data
$ 1.09M$ 825.00K$ 464.00K$ 1.33M
Issuance Of Capital Stock
-$ 112.48M$ 0.00$ 32.95M
Issuance Of Debt
$ 19.76M$ 14.87M$ 0.00$ 11.75M
Repayment Of Debt
$ -15.08M$ -5.08M$ -107.00K$ -9.03M
Free Cash Flow
$ -50.58M$ -38.55M$ -15.59M$ -6.47M
Domestic Sales
----
Foreign Sales
----
Currency in USD

Codex DNA Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis